LV11821B - Use of creatine phosphate or phosphoenolpyruvic acid for the treatment of tumours - Google Patents
Use of creatine phosphate or phosphoenolpyruvic acid for the treatment of tumours Download PDFInfo
- Publication number
- LV11821B LV11821B LVP-97-18A LV970018A LV11821B LV 11821 B LV11821 B LV 11821B LV 970018 A LV970018 A LV 970018A LV 11821 B LV11821 B LV 11821B
- Authority
- LV
- Latvia
- Prior art keywords
- des
- les
- phosphate
- une
- use according
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9114967A FR2684381B1 (fr) | 1991-12-03 | 1991-12-03 | Composes presentant une liaison amide phosphorique ou une liaison phosphate d'enol pour leur application en tant que substance therapeutiquement active. |
| PCT/FR1992/001118 WO1993010792A1 (fr) | 1991-12-03 | 1992-12-01 | Utilisation de la creatine phosphate ou de l'acide phosphoenol pyruvique pour le traitement des tumeurs |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| LV11821A LV11821A (lv) | 1997-08-20 |
| LV11821B true LV11821B (en) | 1997-12-20 |
Family
ID=9419629
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LVP-97-18A LV11821B (en) | 1991-12-03 | 1997-02-05 | Use of creatine phosphate or phosphoenolpyruvic acid for the treatment of tumours |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US5219846A (cs) |
| EP (1) | EP0614366B1 (cs) |
| JP (1) | JP3437574B2 (cs) |
| KR (1) | KR100235893B1 (cs) |
| AT (1) | ATE142499T1 (cs) |
| AU (1) | AU3260093A (cs) |
| BG (1) | BG61595B1 (cs) |
| CA (1) | CA2124793C (cs) |
| CZ (1) | CZ284966B6 (cs) |
| DE (1) | DE69213757T2 (cs) |
| DK (1) | DK0614366T3 (cs) |
| ES (1) | ES2094522T3 (cs) |
| FR (1) | FR2684381B1 (cs) |
| GR (1) | GR3021876T3 (cs) |
| HU (1) | HU216826B (cs) |
| LV (1) | LV11821B (cs) |
| RO (1) | RO115784B1 (cs) |
| RU (1) | RU2097040C1 (cs) |
| SK (1) | SK280785B6 (cs) |
| UA (1) | UA41285C2 (cs) |
| WO (1) | WO1993010792A1 (cs) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1994016712A1 (en) * | 1993-01-27 | 1994-08-04 | Amira, Inc. | Creatine phosphate, creatine phosphate analogs, and uses therefor |
| WO1994016687A1 (en) * | 1993-01-28 | 1994-08-04 | The Trustees Of The University Of Pennsylvania | Use of creatine or analogs for the manufacture of a medicament for inhibiting tumor growth |
| US5714361A (en) * | 1994-02-14 | 1998-02-03 | Indiana University Foundation | Phosphatase/phosphodiesterase enzyme inhibitors and methods |
| US5627172A (en) * | 1994-03-04 | 1997-05-06 | Natural Supplement Association, Incorporated | Method for reduction of serum blood lipids or lipoprotein fraction |
| DE19537494C2 (de) * | 1995-09-25 | 1997-10-02 | Desitin Arzneimittel Gmbh | Kreatin zum Schutz von neuralem Gewebe |
| DE19653225A1 (de) * | 1996-12-20 | 1998-06-25 | Sueddeutsche Kalkstickstoff | Kreatin-pyruvate und Verfahren zu deren Herstellung |
| DE10116589A1 (de) * | 2001-04-03 | 2002-10-10 | Wulf Droege | Anwendung von Kreatin zur Minderung von oxidativem Stress |
| RU2309747C2 (ru) * | 2002-09-18 | 2007-11-10 | Михаил Владимирович Кутушов | Применение 2-хлорэтилфосфоновой кислоты и ее солей в качестве противоопухолевого средства |
| JP5172146B2 (ja) * | 2003-05-09 | 2013-03-27 | ザ・トラスティーズ・オブ・ザ・ユニバーシティ・オブ・ペンシルバニア | 癌を標的化するための組成物及び方法 |
| RU2354645C1 (ru) * | 2007-11-21 | 2009-05-10 | Закрытое Акционерное Общество "Вертекс" | Амиды креатина, способ их получения, средство, обладающее нейропротекторным действием |
| WO2010074591A1 (ru) | 2008-12-24 | 2010-07-01 | Закрытое Акционерное Общество "Beptekc" | Амиды креатина, способ их получения, средство, обладающее нейропротекторным действием |
| RU2428414C2 (ru) | 2009-11-03 | 2011-09-10 | Закрытое Акционерное Общество "Вертекс" | Способ получения амидов креатина |
| US20160061919A1 (en) * | 2014-07-09 | 2016-03-03 | Sidra Medical and Research Center | Imaging of creatine kinase enzyme expression in cancerous tissues |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE8200252L (sv) * | 1982-01-18 | 1983-07-19 | Pharmacia Ab | Farmaceutisk komposition |
| IT1214598B (it) * | 1985-04-17 | 1990-01-18 | Schiapparelli Farma | Uso terapeutico della fosfocreatina. |
| IT1191639B (it) * | 1985-11-11 | 1988-03-23 | Schiapparelli Farma | Composizione farmaceutica contenente fosfocreatina e metodo per preparla |
| US4874882A (en) * | 1986-03-25 | 1989-10-17 | Ube Industries, Ltd. | Process for preparing monosodium phosphoenolpyruvate |
| US4769318A (en) * | 1986-06-03 | 1988-09-06 | Ube Industries, Ltd. | Additive solution for blood preservation and activation |
-
1991
- 1991-12-03 FR FR9114967A patent/FR2684381B1/fr not_active Expired - Lifetime
- 1991-12-20 US US07/811,058 patent/US5219846A/en not_active Expired - Lifetime
-
1992
- 1992-12-01 RU RU9294030808A patent/RU2097040C1/ru not_active IP Right Cessation
- 1992-12-01 EP EP93901806A patent/EP0614366B1/fr not_active Expired - Lifetime
- 1992-12-01 ES ES93901806T patent/ES2094522T3/es not_active Expired - Lifetime
- 1992-12-01 SK SK683-94A patent/SK280785B6/sk not_active IP Right Cessation
- 1992-12-01 DK DK93901806.5T patent/DK0614366T3/da active
- 1992-12-01 UA UA94005324A patent/UA41285C2/uk unknown
- 1992-12-01 KR KR1019940701870A patent/KR100235893B1/ko not_active Expired - Fee Related
- 1992-12-01 CZ CZ941343A patent/CZ284966B6/cs not_active IP Right Cessation
- 1992-12-01 JP JP50989193A patent/JP3437574B2/ja not_active Expired - Fee Related
- 1992-12-01 AT AT93901806T patent/ATE142499T1/de active
- 1992-12-01 WO PCT/FR1992/001118 patent/WO1993010792A1/fr not_active Ceased
- 1992-12-01 AU AU32600/93A patent/AU3260093A/en not_active Abandoned
- 1992-12-01 CA CA002124793A patent/CA2124793C/en not_active Expired - Fee Related
- 1992-12-01 DE DE69213757T patent/DE69213757T2/de not_active Expired - Lifetime
- 1992-12-01 RO RO94-00930A patent/RO115784B1/ro unknown
- 1992-12-01 HU HU9401656A patent/HU216826B/hu not_active IP Right Cessation
-
1994
- 1994-06-01 BG BG98825A patent/BG61595B1/bg unknown
-
1996
- 1996-12-04 GR GR960403287T patent/GR3021876T3/el unknown
-
1997
- 1997-02-05 LV LVP-97-18A patent/LV11821B/lv unknown
Also Published As
| Publication number | Publication date |
|---|---|
| FR2684381A1 (fr) | 1993-06-04 |
| UA41285C2 (uk) | 2001-09-17 |
| CA2124793C (en) | 2005-09-20 |
| CZ284966B6 (cs) | 1999-04-14 |
| EP0614366B1 (fr) | 1996-09-11 |
| DE69213757D1 (de) | 1996-10-17 |
| JPH07501534A (ja) | 1995-02-16 |
| HU9401656D0 (en) | 1994-09-28 |
| AU3260093A (en) | 1993-06-28 |
| GR3021876T3 (en) | 1997-03-31 |
| SK68394A3 (en) | 1995-03-08 |
| EP0614366A1 (fr) | 1994-09-14 |
| RO115784B1 (ro) | 2000-06-30 |
| ATE142499T1 (de) | 1996-09-15 |
| BG61595B1 (bg) | 1998-01-30 |
| BG98825A (bg) | 1995-05-31 |
| LV11821A (lv) | 1997-08-20 |
| CZ134394A3 (en) | 1994-12-15 |
| US5219846A (en) | 1993-06-15 |
| DK0614366T3 (da) | 1996-11-25 |
| HU216826B (hu) | 1999-09-28 |
| FR2684381B1 (fr) | 1995-05-05 |
| RU94030808A (ru) | 1996-10-20 |
| WO1993010792A1 (fr) | 1993-06-10 |
| HUT68876A (en) | 1995-08-28 |
| SK280785B6 (sk) | 2000-07-11 |
| DE69213757T2 (de) | 1997-04-03 |
| CA2124793A1 (en) | 1993-06-10 |
| ES2094522T3 (es) | 1997-01-16 |
| RU2097040C1 (ru) | 1997-11-27 |
| JP3437574B2 (ja) | 2003-08-18 |
| KR100235893B1 (ko) | 1999-12-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| LV11821B (en) | Use of creatine phosphate or phosphoenolpyruvic acid for the treatment of tumours | |
| US6506783B1 (en) | Cancer treatments and pharmaceutical compositions therefor | |
| Senter et al. | Enhancement of the in vitro and in vivo antitumor activities of phosphorylated mitomycin C and etoposide derivatives by monoclonal antibody-alkaline phosphatase conjugates | |
| SK99199A3 (en) | Kit for inhibiting the growth of cancers, comprising a chemotherapeutic agent and a benzimidazole, and optionally a potentiator | |
| EA026870B1 (ru) | Комбинация и фармацевтическая композиция для лечения опухолей | |
| SK87993A3 (en) | Pharmaceutical composition | |
| EP1601686A1 (de) | Protein-bindende doxorubicin-peptid-derivate | |
| Molin | Oral acyclovir prevents herpes simplex virus‐associated erythema multiforme | |
| AU2002221622B2 (en) | Antitumor therapy comprising distamycin derivatives | |
| CN1296818A (zh) | 用于含癌的恶性新生物的抗恶性肿瘤剂 | |
| ES2278702T3 (es) | Composicion para el tratamiento de metastasis o del cancer, que contiene fluorouracilo y un agente de transferencia de metilol. | |
| EP3967310B1 (en) | Quinoline derivative and epirubicin used for soft tissue sarcoma combination therapy | |
| JP4395368B2 (ja) | 細胞殺傷活性を有するカルシウム塩 | |
| ES2317913T3 (es) | Tratamiento antitumoral combinado que comprende un derivado de la distamicina sustituida por acriloilo y un antimetabolito. | |
| EP1372733B1 (en) | Pharmaceutical compositions of active polypeptides for enhanced pharmacological activity through oral and parenteral administration | |
| JPH0378368B2 (cs) | ||
| KR100844477B1 (ko) | 항종양 효과 증강제, 항종양제 및 암 치료 방법 | |
| JPH02215726A (ja) | 糖尿病治療剤 | |
| CN1110319C (zh) | 含蚯蚓纤溶酶的抗肿瘤药剂和保健品 | |
| KR101320485B1 (ko) | 데커신 및/또는 데커시놀 안젤레이트, 또는 데커신및/또는 데커시놀 안젤레이트를 유효성분으로 하는당귀추출물을 포함하는 항암제 조성물 | |
| JPH0667834B2 (ja) | 抗腫瘍剤 | |
| JP4382354B2 (ja) | １−ブタン酸誘導体およびその使用 | |
| Mori | An outline of RAFP therapy | |
| CN102020653A (zh) | 氨基全氢化喹唑啉类化合物及其衍生物制备提高抗癌药药效的新应用 | |
| JPH0558892A (ja) | 発癌防止剤 |